RadNet, Inc. logo RDNT - RadNet, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 8
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $86.00 DETAILS
HIGH: $92.00
LOW: $65.00
MEDIAN: $91.00
CONSENSUS: $86.00
UPSIDE: 58.09%

Stock News

RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

LOS ANGELES, May 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 435 outpatient imaging centers and a premier developer of radiology digital health solutions, today reported financial results for its first quarter of 2026.

May 10, 2026 12:05 PM globenewswire.com
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call

RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call

LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today that it will host a conference call to discuss its first quarter 2026 financial results on Monday, May 11, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Apr 28, 2026 02:00 AM globenewswire.com
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions

GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and w.

Apr 16, 2026 12:05 PM businesswire.com
RadNet's Pullback Offers Upside With Outpatient Imaging And AI

RadNet's Pullback Offers Upside With Outpatient Imaging And AI

RadNet combines a scaled outpatient imaging platform with DeepHealth. This is their AI-enabled radiology software segment that adds growth optionality. RDNT's core imaging demand also remains strong, helped by outpatient site-of-care trends, but their acquisitions and hospital joint ventures are part of the story. Management reported record Q4 2025 revenue, while underlying organic growth suggests the base imaging business is still healthy.

Mar 07, 2026 03:04 AM seekingalpha.com
RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS

RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS

LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet's Digital Health strategy. On the call, investors will also have the opportunity to ask questions of executive management.

Mar 04, 2026 01:00 AM globenewswire.com

Price Targets